Hi all, I've noticed a few hospitals that are drawing up T-VEC in their hoods into syringes to dispense and was wondering if anyone else is doing this?

The PI does not recommend this and states not to do this until right before administration - previously in my last hospital we also dispensed the vials directly to the consultant.

I was wondering as well is there anyone here that was involved in the clinical trials for T-VEC and hence might be privvy to longer stability data/reconstitution times used during the trial that might differ from what is being marketed.

Does anyone have a framework for what to evaluate when comparing biomedical service vendors? From the pharmacy perspective, availability and expertise in updating non-wireless libraries is what comes to mind.
Appreciate any thoughts from others who have been involved in a similar process.
thanks

We've considered adding this "class" to our high alert medication list. Only happens very rarely, since we already have may approved "double concentrated" drips. I supposed it would be challenging to even detect how often non-standard concentrations are built.

I'm pretty concerned that a surveyor may not appreciate seeing this class on our list. Although acknowledging the risk and trying to address it may be better than ignoring it?

Do people treat mesna and leucovorin as a chemo medication requiring a double signature by nursing because of the complicated dosing calculations and conversions (IV to PO) involved with it? Thank you.

hello!

I was writing today to see if any of you that practice in the ambulatory space might be able to provide insight into your practices in regards to this question:

Do you currently "dispense" medications out of / from your physician (outpatient) offices?

(if so, what medications are you dispensing?, are there certain criteria that have to be met?, who has oversight?, what sort of process is involved including meeting regulatory requirements / labeling, etc.)

Thanks in advance!
Emily

Do you record the lot and expiration of any or all of the following products in your EHR system (either by nursing during administration or by pharmacy at order entry/verification)?
-prolastin
-IVIG
-Kcentra
-Rhogam
-prolastin
-Rabies immune globulin

I noted the FDA has recently updated the "Warnings and Precautions" section of the drug labeling for several paralytics to include a new subsection "Risk of Death Due to Medication Errors".

I don't recall seeing this subsection for other medications but perhaps I am mistaken. Has anyone noticed this subsection added to other agents?

Has anyone been able to compare their inpatient narcan usage with other sites or have you found a benchmark by chance?
Thank you in advance!

Hello -

Recognizing that 'medication error rates' captured by voluntary incident reports is the least effective and least reliable determinant of true error rates / benchmarking....

I wondered if other institutions have developed executive-level (or really any level) benchmarks / dashboards / metrics which they follow in their health system to track performance improvement within medication safety and safety realms?

I would be particularly interested if anyone has develop these measures in the outpatient / ambulatory spaces as well.

Hey safety gurus!

Wanted to know if anyone has any input/guidance regarding having a default age/DOB for the pediatric unknown patient (e.g., trauma patient) in order to get the patient registered and allow orders to be entered. EPIC is our EMR and most things (alerts, normal ranges, etc) are based on age and weight. We are trying to find a way to choose a default age/DOB that allows us to get the patient registered and orders entered, while maintaining our medication and lab safeguards.

Thanks in advance for any help that you can provide.

-Jameika